Publications

Mazzolini R; Gonzàlez N; Garcia-Garijo A; Millanes-Romero A; Peiró S; Smith S; García de Herreros A; Canudas S, 2018. Snail1 transcription factor controls telomere transcription and integrity.  Nucleic Acids Res 46(1):146-158

Mateo-Lozano S; Bazzocco S; Rodrigues P; Mazzolini R; Andretta E; Dopeso H; Fernández Y; Del Llano E; Bilic J; Suárez-López L; Macaya I; Cartón-García F; Nieto R; Jimenez-Flores LM; de Marcondes PG; Nuñez Y; Afonso E; Cacci K; Hernández-Losa J; Landolfi S; Abasolo I; Ramón Y Cajal S; Mariadason JM; Schwartz S Jr; Matsui T; Arango D, 2017. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.  Sci Rep 7:43702

Beltran M; Aparicio-Prat E; Mazzolini R; Millanes-Romero A; Massó P; Jenner RG; Díaz VM; Peiró S; de Herreros AG, 2015. Splicing of a non-coding antisense transcript controls LEF1 gene expression.  Nucleic Acids Res 43(12):5785-97

Peláez-García A; Barderas R; Batlle R; Viñas-Castells R; Bartolomé RA; Torres S; Mendes M; Lopez-Lucendo M; Mazzolini R; Bonilla F; García de Herreros A; Casal JI, 2015. A proteomic analysis reveals that Snail regulates the expression of the nuclear orphan receptor Nuclear Receptor Subfamily 2 Group F Member 6 (Nr2f6) and interleukin 17 (IL-17) to inhibit adipocyte differentiation.  Mol Cell Proteomics 14(2):303-15

Rodrigues P; Macaya I; Bazzocco S; Mazzolini R; Andretta E; Dopeso H; Mateo-Lozano S; Bilić J; Cartón-García F; Nieto R; Suárez-López L; Afonso E; Landolfi S; Hernandez-Losa J; Kobayashi K; Ramón y Cajal S; Tabernero J; Tebbutt NC; Mariadason JM; Schwartz S Jr; Arango D, 2014. RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.  Nat Commun 5:5458

Alba-Castellón L; Batlle R; Francí C; Fernández-Aceñero MJ; Mazzolini R; Peña R; Loubat J; Alameda F; Rodríguez R; Curto J; Albanell J; Muñoz A; Bonilla F; Ignacio Casal J; Rojo F; García de Herreros A, 2014. Snail1 expression is required for sarcomagenesis.  Neoplasia 16(5):413-21

Mazzolini R; Rodrigues P; Bazzocco S; Dopeso H; Ferreira AM; Mateo-Lozano S; Andretta E; Woerner SM; Alazzouzi H; Landolfi S; Hernandez-Losa J; Macaya I; Suzuki H; Ramón y Cajal S; Mooseker MS; Mariadason JM; Gebert J; Hofstra RM; Reventós J; Yamamoto H; Schwartz S Jr; Arango D, 2013. Brush border myosin Ia inactivation in gastric but not endometrial tumors.  Int J Cancer 132(8):1790-9

Arango D; Al-Obaidi S; Williams DS; Dopeso H; Mazzolini R; Corner G; Byun DS; Carr AA; Murone C; Tögel L; Zeps N; Aaltonen LA; Iacopetta B; Mariadason JM, 2012. Villin expression is frequently lost in poorly differentiated colon cancer.  Am J Pathol 180(4):1509-21

Mazzolini R; Dopeso H; Mateo-Lozano S; Chang W; Rodrigues P; Bazzocco S; Alazzouzi H; Landolfi S; Hernández-Losa J; Andretta E; Alhopuro P; Espín E; Armengol M; Tabernero J; Ramón y Cajal S; Kloor M; Gebert J; Mariadason JM; Schwartz S Jr; Aaltonen LA; Mooseker MS; Arango D, 2012. Brush border myosin Ia has tumor suppressor activity in the intestine.  Proc Natl Acad Sci U S A 109(5):1530-5

Dopeso H; Mateo-Lozano S; Elez E; Landolfi S; Ramos Pascual FJ; Hernández-Losa J; Mazzolini R; Rodrigues P; Bazzocco S; Carreras MJ; Espín E; Armengol M; Wilson AJ; Mariadason JM; Ramon Y Cajal S; Tabernero J; Schwartz S Jr; Arango D, 2010. Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.  Clin Cancer Res 16(8):2375-82

Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S Jr; Arango D, 2009. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.  Cancer Res 69(18):7430-8

Publication list retrieved from NCBI using ImpactPubs

.